Medical News

RSS

Boston Scientific completes enrollment in Nitinol Stent System trial for treatment of iliac artery disease

Boston Scientific Corporation today announced that it has completed enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC™ Self-Expanding Nitinol Stent System for the treatment of iliac artery disease, a form of peripheral artery disease associated with severe leg pain caused by insufficient blood flow to the muscles (claudication).

10 Jan 2011

Obama administration sides with drug companies in pricing lawsuit; Supreme Court agrees to hear case regarding use of prescription drug data

At issue are charges to public hospitals and clinics that treat a large number of poor patients and a Vermont law that restricts prescription drug data.

10 Jan 2011

Walker & Dunlop provides $104.7 million for acquisition of 18 skilled nursing facilities

Walker & Dunlop, LLC announced today that on December 29, 2010, it provided $104.7 million of acquisition funding to Ark Holding Company for the purchase of 18 skilled nursing facilities located in South Carolina, North Carolina and Georgia. This transaction represents Walker & Dunlop's second large-scale skilled nursing financing in 2010 exceeding $100 million.

10 Jan 2011

Shionogi brings KAPVAY ADHD drug to the U.S market

Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced a true milestone as it marks the first commercial availability for the non-central nervous system stimulant medication KAPVAY™, an extended-release oral formulation of clonidine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents.

10 Jan 2011

Political dynamics, stakeholder positions clarify in the next chapter of the health debate

Just as the repeal positions of some big insurers are becoming more clear, more details on the Democrats' strategy to defend the law are emerging.

10 Jan 2011

nContact Surgical removes 'Surgical' from company name

nContact Surgical, Inc., a cardiac ablation device manufacturer, announced today that it is changing the name under which it operates from nContact Surgical, Inc. to nContact, Inc. As the pioneer of interdisciplinary epicardial and endocardial cardiac ablation, the change represents the Company's further evolution towards closed chest approaches to treating common cardiac arrhythmias.

10 Jan 2011

How the overhaul's small business tax credit is working

Kansas Health Institute News explores how tax credits — one existing at the state level and the new one put in place by the health law — may be encouraging small business owners to provide health coverage to their employees.

10 Jan 2011

Mindray anticipates $703 million net revenue for 2010

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2010.

From Mindray 10 Jan 2011

VisionCare announces closing of $31 million Series E financing

VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices designed to improve vision in patients with end-stage age-related macular degeneration (AMD), announced today it has closed a Series E financing totaling $31 million.

10 Jan 2011

CMS issues rule to reward hospitals for high-quality care

This proposed rule, which is required by the health law, outlines how Medicare will reward hospitals for delivering high-quality care.

10 Jan 2011

Advanced Targeting Systems awarded $3 million NCI grant to advance SP-SAP clinical program

Advanced Pain Remedies, a subsidiary of Cato BioVentures, announces that a three million dollar grant has been received, to advance its lead development candidate, SP-SAP. Advanced Targeting Systems, the company that pioneered the targeting of specific cell types to manipulate them for the treatment of diseases, has been awarded a $3 million grant from the National Cancer Institute (NCI).

10 Jan 2011

House postpones repeal vote, tones down rhetoric

House Republicans have called off [this] week's legislative action, including a planned Wednesday vote on a GOP bill to repeal President Obama's health care law, because of today's shooting attack on Rep. Gabrielle Giffords, D-Ariz., and others in Tucson. Giffords supported the law (Davis and House, 1/8).

10 Jan 2011

Vicept reports positive data from V-101 Phase II clinical trial for Type I Rosacea

Vicept Therapeutics, Inc. announced positive study results from a Phase II clinical trial evaluating the dose-response relationship of four concentrations of V-101 cream, a topical cream for the treatment of Type I Rosacea (Erythematotelangiectatic Rosacea). The results demonstrated a statistically significantrebound" or tachyphylaxis was observed.

10 Jan 2011

OpEds: Health reform repeal; CBO's numbers; Reviving public option?

[A]s a political matter, an outright repeal isn't really a winner. Most Americans dislike the law, but few are gunning to do away with it altogether. They don't like its mandates and costs, but they'd prefer to see a scaled down law that still provides more access to health care. Republicans run the risk of overreaching on this, as Democrats did in pushing a vast expansion of government into the health care field.

10 Jan 2011

T2 Biosystems relocates to new 20,000 sq.ft. facility in Lexington

T2 Biosystems, Inc., a company developing next-generation medical diagnostic products, today announced that it has relocated to a newly renovated 20,000 sq.ft. facility located in Lexington, MA.

10 Jan 2011

ACADIA raises $15 million through private placement

ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has entered into a securities purchase agreement for a private placement financing with a select group of institutional investors, including New Enterprise Associates and Venrock.

10 Jan 2011

Neomend receives CE Mark for ProGEL PLATINUM Surgical Sealant

Neomend, Inc., an innovator in sealant and adhesion-prevention products for the surgical marketplace, announced it has received the European Union CE Mark for the company's ProGEL® PLATINUM Surgical Sealant.

10 Jan 2011

Neuroptix announces closing of $4 million Series C funding round

Neuroptix Corporation, a leading innovator in the early detection of Alzheimer's Disease through a non-invasive eye test, today announced that it has closed the first approximately $4 Million tranche of a Series C funding round, as the company continues clinical development of its diagnostic platform.

10 Jan 2011

EffRx submits EX101 NDA for osteoporosis treatment to FDA

EffRx Pharmaceuticals SA, a Lausanne, Switzerland based drug delivery company announces the NDA submission of the company's lead project to the US Food and Drug Administration.

10 Jan 2011

Manhattan enters settlement and release agreement with Nordic and H Pharmaceuticals

Manhattan Pharmaceuticals, Inc. announced that on January 4, 2011, the company entered into a settlement and release agreement with Nordic Biotech Fund II K/S and H Pharmaceuticals K/S. Manhattan Pharmaceuticals and Nordic are partners in the H Pharmaceuticals joint venture for the development and commercialization of Hedrin®, a non-pesticide treatment for head lice.

10 Jan 2011

Medical News

Boston Scientific completes enrollment in Nitinol Stent System trial for treatment of iliac artery disease

Obama administration sides with drug companies in pricing lawsuit; Supreme Court agrees to hear case regarding use of prescription drug data

Walker & Dunlop provides $104.7 million for acquisition of 18 skilled nursing facilities

Shionogi brings KAPVAY ADHD drug to the U.S market

Political dynamics, stakeholder positions clarify in the next chapter of the health debate

nContact Surgical removes 'Surgical' from company name

How the overhaul's small business tax credit is working

Mindray anticipates $703 million net revenue for 2010

VisionCare announces closing of $31 million Series E financing

CMS issues rule to reward hospitals for high-quality care

Advanced Targeting Systems awarded $3 million NCI grant to advance SP-SAP clinical program

House postpones repeal vote, tones down rhetoric

Vicept reports positive data from V-101 Phase II clinical trial for Type I Rosacea

OpEds: Health reform repeal; CBO's numbers; Reviving public option?

T2 Biosystems relocates to new 20,000 sq.ft. facility in Lexington

ACADIA raises $15 million through private placement

Neomend receives CE Mark for ProGEL PLATINUM Surgical Sealant

Neuroptix announces closing of $4 million Series C funding round

EffRx submits EX101 NDA for osteoporosis treatment to FDA

Manhattan enters settlement and release agreement with Nordic and H Pharmaceuticals

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News